AKR1C8
gene geneOn this page
Summary
AKR1C8 (aldo-keto reductase family 1 member C8, HGNC:23469) is a protein-coding gene on chromosome 10p15.1, encoding Aldo-keto reductase family 1 member C8 (Q5T2L2).
Predicted to enable aldo-keto reductase (NADPH) activity and estradiol 17-beta-dehydrogenase [NAD(P)+] activity. Predicted to be involved in prostaglandin biosynthetic process. Predicted to be located in cytoplasm.
Source: NCBI Gene 340811 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001395972
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23469 |
| Approved symbol | AKR1C8 |
| Name | aldo-keto reductase family 1 member C8 |
| Location | 10p15.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000264006 |
| Ensembl biotype | protein_coding |
| Entrez | 340811 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000578467, ENST00000584929, ENST00000648824, ENST00000650030
RefSeq mRNA: 1 — MANE Select: NM_001395972
NM_001395972
CCDS: CCDS91207
Canonical transcript exons
ENST00000648824 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003831942 | 5161856 | 5161972 |
| ENSE00003833891 | 5160812 | 5160889 |
| ENSE00003834526 | 5162853 | 5163020 |
| ENSE00003835563 | 5159883 | 5160005 |
| ENSE00003836125 | 5157635 | 5157800 |
| ENSE00003837835 | 5155675 | 5155757 |
| ENSE00003839032 | 5158600 | 5158709 |
| ENSE00003978319 | 5185012 | 5185150 |
| ENSE00003978320 | 5153920 | 5154182 |
Expression profiles
Bgee: expression breadth broad, 56 present calls, max score 88.86.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0737 / max 46.0029, expressed in 14 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 108072 | 0.0737 | 14 |
Top tissues by expression
102 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.86 | gold quality |
| right lobe of liver | UBERON:0001114 | 88.09 | gold quality |
| liver | UBERON:0002107 | 85.96 | gold quality |
| granulocyte | CL:0000094 | 59.71 | gold quality |
| calcaneal tendon | UBERON:0003701 | 59.28 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 54.35 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 50.82 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 48.97 | gold quality |
| heart left ventricle | UBERON:0002084 | 48.84 | gold quality |
| blood | UBERON:0000178 | 45.69 | gold quality |
| adipose tissue | UBERON:0001013 | 45.31 | gold quality |
| colonic epithelium | UBERON:0000397 | 44.60 | gold quality |
| heart | UBERON:0000948 | 43.97 | gold quality |
| right atrium auricular region | UBERON:0006631 | 43.19 | gold quality |
| kidney | UBERON:0002113 | 43.04 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 42.75 | gold quality |
| bone marrow cell | CL:0002092 | 41.61 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 41.15 | gold quality |
| cortex of kidney | UBERON:0001225 | 41.01 | gold quality |
| omental fat pad | UBERON:0010414 | 40.78 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 40.37 | gold quality |
| corpus callosum | UBERON:0002336 | 40.14 | gold quality |
| bone marrow | UBERON:0002371 | 39.81 | silver quality |
| right lung | UBERON:0002167 | 39.79 | silver quality |
| right testis | UBERON:0004534 | 39.47 | gold quality |
| right uterine tube | UBERON:0001302 | 38.67 | silver quality |
| sural nerve | UBERON:0015488 | 37.82 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 37.78 | silver quality |
| testis | UBERON:0000473 | 37.51 | gold quality |
| left testis | UBERON:0004533 | 37.16 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.91 |
Regulation
Is transcription factor: no
Cross-species orthologs
19 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zgc:110366 | ENSDARG00000004167 |
| danio_rerio | akr1a1a | ENSDARG00000035257 |
| danio_rerio | zgc:110782 | ENSDARG00000044544 |
| danio_rerio | zgc:101765 | ENSDARG00000054934 |
| danio_rerio | zgc:56622 | ENSDARG00000099728 |
| rattus_norvegicus | Akr1c15 | ENSRNOG00000021735 |
| drosophila_melanogaster | CG6083 | FBGN0036183 |
| drosophila_melanogaster | CG18547 | FBGN0037973 |
| drosophila_melanogaster | CG3397 | FBGN0037975 |
| caenorhabditis_elegans | WBGENE00003176 | |
| caenorhabditis_elegans | WBGENE00009980 | |
| caenorhabditis_elegans | WBGENE00009981 | |
| caenorhabditis_elegans | WBGENE00012722 | |
| caenorhabditis_elegans | WBGENE00012723 | |
| caenorhabditis_elegans | WBGENE00015307 | |
| caenorhabditis_elegans | WBGENE00015564 | |
| caenorhabditis_elegans | WBGENE00015565 | |
| caenorhabditis_elegans | WBGENE00016985 | |
| caenorhabditis_elegans | WBGENE00022887 |
Paralogs (16): AKR7A2 (ENSG00000053371), KCNAB2 (ENSG00000069424), AKR1B1 (ENSG00000085662), AKR1A1 (ENSG00000117448), AKR1D1 (ENSG00000122787), AKR1C2 (ENSG00000151632), AKR7A3 (ENSG00000162482), AKR1E2 (ENSG00000165568), KCNAB1 (ENSG00000169282), KCNAB3 (ENSG00000170049), AKR1C1 (ENSG00000187134), AKR1C3 (ENSG00000196139), AKR1B10 (ENSG00000198074), AKR1C4 (ENSG00000198610), AKR7L (ENSG00000211454), AKR1B15 (ENSG00000227471)
Protein
Protein identifiers
Aldo-keto reductase family 1 member C8 — Q5T2L2 (reviewed: Q5T2L2)
Alternative names: Aldo-keto reductase family 1 member C-like protein 1
All UniProt accessions (2): A0A3B3IRI8, Q5T2L2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Similarity. Belongs to the aldo/keto reductase family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5T2L2-1 | 1 | yes |
| Q5T2L2-3 | 2 |
RefSeq proteins (1): NP_001382901* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018170 | Aldo/ket_reductase_CS | Conserved_site |
| IPR020471 | AKR | Family |
| IPR023210 | NADP_OxRdtase_dom | Domain |
| IPR036812 | NAD(P)_OxRdtase_dom_sf | Homologous_superfamily |
| IPR044482 | AKR1C | Family |
Pfam: PF00248
UniProt features (13 total): binding site 6, splice variant 2, site 2, chain 1, active site 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5T2L2-F1 | 95.88 | 0.94 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 58 (proton donor); 57 (important for substrate specificity); 87 (lowers pka of active site tyr)
Ligand- & substrate-binding residues (6): 25–27; 53; 120; 169–170; 193; 271–283
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 11 (showing top):
GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, chr10p15, GOBP_STEROID_METABOLIC_PROCESS, GOBP_ALCOHOL_METABOLIC_PROCESS, GOMF_OXIDOREDUCTASE_ACTIVITY, GOBP_HORMONE_METABOLIC_PROCESS, GOBP_SMALL_MOLECULE_METABOLIC_PROCESS, GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN
GO Biological Process (4): alcohol metabolic process (GO:0006066), steroid metabolic process (GO:0008202), monocarboxylic acid metabolic process (GO:0032787), hormone metabolic process (GO:0042445)
GO Molecular Function (2): oxidoreductase activity (GO:0016491), protein binding (GO:0005515)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| small molecule metabolic process | 1 |
| lipid metabolic process | 1 |
| carboxylic acid metabolic process | 1 |
| metabolic process | 1 |
| regulation of hormone levels | 1 |
| catalytic activity | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
682 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| AKR1C8 | ASAH2B | P0C7U1 | 433 |
| AKR1C8 | TRIM2 | Q9C040 | 422 |
| AKR1C8 | HMSD | A8MTL9 | 417 |
| AKR1C8 | AKR7A3 | O95154 | 405 |
| AKR1C8 | TSPAN32 | Q96QS1 | 399 |
| AKR1C8 | HOXA2 | O43364 | 350 |
| AKR1C8 | GGT1 | P19440 | 324 |
| AKR1C8 | GGTLC3 | B5MD39 | 323 |
| AKR1C8 | FOXP2 | O15409 | 280 |
| AKR1C8 | GGT2P | P36268 | 273 |
| AKR1C8 | TNXB | P22105 | 271 |
| AKR1C8 | GFI1 | Q99684 | 269 |
| AKR1C8 | KCNAB3 | O43448 | 204 |
| AKR1C8 | GDI2 | P50395 | 204 |
| AKR1C8 | GLYCTK | Q8IVS8 | 204 |
| AKR1C8 | ADORA2A | P29274 | 204 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CASP6 | AKR1C8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP2 | AKR1C8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SH3GLB1 | AKR1C8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRPF40A | AKR1C8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AKR1C8 | COQ8A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM55 | AKR1C8 | psi-mi:“MI:0915”(physical association) | 0.000 |
ESM2 similar proteins: A2XRZ0, D3ZF77, O08782, O22707, O60218, P02532, P05980, P07943, P15121, P15122, P16116, P17264, P17516, P21300, P23457, P38918, P40691, P42330, P45376, P45377, P51652, P51857, P52895, P52897, P52898, P70694, P80276, P80508, P97382, Q04828, Q1XAA8, Q5R7C9, Q5REQ0, Q5T2L2, Q640V9, Q6AYQ2, Q6GML7, Q6W8P9, Q7XT99, Q84M96
Diamond homologs: A0A1D5XGW0, A0A1X9QHJ0, A0A2P1GIY9, A0A9E7S518, A0A9E7S5B9, B4F9A4, B9VRJ2, C9JRZ8, D3ZF77, E7C196, H9JTG9, M9PF61, O08782, O32210, O34678, O49133, O60218, O70473, O80944, P02532, P05980, P07943, P0DKI7, P0DXG9, P0DXH7, P14065, P14550, P15121, P15122, P16116, P17264, P17516, P21300, P23457, P23901, P26690, P28475, P31867, P42330, P45376
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2151 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:5162967:G:C | F49L | 0.961 |
| 10:5162967:G:T | F49L | 0.961 |
| 10:5162969:A:G | F49L | 0.961 |
| 10:5162865:G:C | F83L | 0.951 |
| 10:5162865:G:T | F83L | 0.951 |
| 10:5162867:A:G | F83L | 0.951 |
| 10:5185033:A:C | F24L | 0.888 |
| 10:5185033:A:T | F24L | 0.888 |
| 10:5185035:A:G | F24L | 0.888 |
| 10:5161883:G:C | F117L | 0.885 |
| 10:5161883:G:T | F117L | 0.885 |
| 10:5161885:A:G | F117L | 0.885 |
| 10:5162955:A:C | D53E | 0.885 |
| 10:5162955:A:T | D53E | 0.885 |
| 10:5162968:A:G | F49S | 0.866 |
| 10:5162965:C:G | R50P | 0.863 |
| 10:5162853:C:A | K87N | 0.857 |
| 10:5162853:C:G | K87N | 0.857 |
| 10:5161958:G:C | F92L | 0.853 |
| 10:5161958:G:T | F92L | 0.853 |
| 10:5161960:A:G | F92L | 0.853 |
| 10:5162877:T:A | R79S | 0.845 |
| 10:5162877:T:G | R79S | 0.845 |
| 10:5161889:A:C | D115E | 0.842 |
| 10:5161889:A:T | D115E | 0.842 |
| 10:5162956:T:A | D53V | 0.813 |
| 10:5162869:A:T | I82K | 0.793 |
| 10:5162884:A:T | V77D | 0.793 |
| 10:5185034:A:G | F24S | 0.793 |
| 10:5162983:G:T | A44D | 0.792 |
dbSNP variants (sampled 300 via entrez): RS1000018894 (10:5146545 T>A,C), RS1000019874 (10:5184023 T>C), RS1000068057 (10:5146845 A>C,G), RS1000075824 (10:5179540 G>A,C), RS1000107726 (10:5156709 G>A,C), RS1000186364 (10:5116731 T>A), RS1000205404 (10:5160525 T>C), RS1000207925 (10:5124763 G>A,C), RS1000240819 (10:5125011 A>T), RS1000291752 (10:5135218 G>A,T), RS1000435805 (10:5165482 T>C), RS1000476320 (10:5184346 C>T), RS1000477130 (10:5130168 A>C), RS1000487113 (10:5115983 T>C), RS1000647223 (10:5155619 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005024_79 | Pursuit maintenance gain | 2.000000e-07 |
| GCST009391_19 | Metabolite levels | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008433 | pursuit maintenance gain measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| fipronil | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| beta-Naphthoflavone | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.